$BKYI
BIO KEY INTERNATIONAL INC

2017 Q1 Form 10-Q Financial Statement

#000143774917009271 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $1.418M $430.6K
YoY Change 229.39% -33.64%
Cost Of Revenue $660.9K $111.8K
YoY Change 490.92% -19.74%
Gross Profit $757.4K $318.7K
YoY Change 137.62% -37.44%
Gross Profit Margin 53.4% 74.02%
Selling, General & Admin $1.620M $992.5K
YoY Change 63.24% -4.63%
% of Gross Profit 213.91% 311.39%
Research & Development $493.4K $489.4K
YoY Change 0.83% 20.35%
% of Gross Profit 65.15% 153.54%
Depreciation & Amortization $7.819K $11.52K
YoY Change -32.11% 8.6%
% of Gross Profit 1.03% 3.61%
Operating Expenses $2.114M $1.482M
YoY Change 42.62% 2.39%
Operating Profit -$1.356M -$1.163M
YoY Change 16.59% 24.03%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $6.00 -$32.00
YoY Change -118.75% -100.23%
Pretax Income -$1.360M -$1.160M
YoY Change 17.24% 26.09%
Income Tax $912.00
% Of Pretax Income
Net Earnings -$1.356M -$1.163M
YoY Change 16.59% 25.87%
Net Earnings / Revenue -95.62% -270.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.789M -$1.681M
COMMON SHARES
Basic Shares Outstanding 6.097M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.160M $3.470M
YoY Change -66.57% 1056.67%
Cash & Equivalents $1.158M $3.475M
Short-Term Investments
Other Short-Term Assets $117.9K $147.1K
YoY Change -19.86% 33.73%
Inventory $571.0K $458.9K
Prepaid Expenses
Receivables $562.5K $2.224M
Other Receivables $120.0K $150.0K
Total Short-Term Assets $4.407M $11.40M
YoY Change -61.36% 842.56%
LONG-TERM ASSETS
Property, Plant & Equipment $60.00K $71.65K
YoY Change -16.26% -20.39%
Goodwill
YoY Change
Intangibles $144.6K $144.3K
YoY Change 0.2%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $11.22M $7.225M
YoY Change 55.26% 2678.73%
TOTAL ASSETS
Total Short-Term Assets $4.407M $11.40M
Total Long-Term Assets $11.22M $7.225M
Total Assets $15.62M $18.63M
YoY Change -16.13% 1167.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.7K $628.6K
YoY Change -75.55% 49.67%
Accrued Expenses $380.0K $312.1K
YoY Change 21.77% -33.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.625M $1.701M
YoY Change -4.45% 14.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.625M $1.701M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.625M $1.701M
YoY Change -4.45% 14.16%
SHAREHOLDERS EQUITY
Retained Earnings -$64.16M -$59.77M
YoY Change 7.33%
Common Stock $610.00 $6.620K
YoY Change -90.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.00M $16.93M
YoY Change
Total Liabilities & Shareholders Equity $15.62M $18.63M
YoY Change -16.13% 1167.32%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$1.356M -$1.163M
YoY Change 16.59% 25.87%
Depreciation, Depletion And Amortization $7.819K $11.52K
YoY Change -32.11% 8.6%
Cash From Operating Activities $117.0K -$661.6K
YoY Change -117.68% 27.42%
INVESTING ACTIVITIES
Capital Expenditures $13.89K $19.29K
YoY Change -27.97%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.89K -$19.29K
YoY Change -27.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.946K -165.6K
YoY Change -96.41% 691.83%
NET CHANGE
Cash From Operating Activities 117.0K -661.6K
Cash From Investing Activities -13.89K -19.29K
Cash From Financing Activities -5.946K -165.6K
Net Change In Cash 97.11K -846.4K
YoY Change -111.47% 56.71%
FREE CASH FLOW
Cash From Operating Activities $117.0K -$661.6K
Capital Expenditures $13.89K $19.29K
Free Cash Flow $103.1K -$680.9K
YoY Change -115.14% 31.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
341160
CY2016Q1 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
CY2016Q1 bkyi Class Of Warrant Or Right Nonemployee Compensation Expense
ClassOfWarrantOrRightNonemployeeCompensationExpense
11625
CY2017Q1 bkyi Expected Operational Costs Per Month
ExpectedOperationalCostsPerMonth
592000
CY2017Q1 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
353671
CY2016Q1 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
160918
CY2017Q1 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
471562
CY2016Q1 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
214556
CY2011Q4 bkyi Factoring Arrangement Term
FactoringArrangementTerm
P2Y
CY2017Q1 bkyi Factoring Fees
FactoringFees
48391
CY2016Q1 bkyi Factoring Fees
FactoringFees
195012
CY2017Q1 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
-53628
CY2016Q1 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
CY2017Q1 bkyi Percentage Of Remaining Balance Owned Reserved
PercentageOfRemainingBalanceOwnedReserved
0.48
CY2017Q1 bkyi Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValueAmount
2660122
CY2017Q1 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
1830000
CY2016Q4 bkyi Software License Rights Current
SoftwareLicenseRightsCurrent
1560000
CY2017Q1 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
9933623
CY2016Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
10598411
CY2017Q1 bkyi Sotware License Rights
SotwareLicenseRights
11763623
CY2016Q4 bkyi Sotware License Rights
SotwareLicenseRights
12158411
CY2017Q1 bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
5003
CY2016Q1 bkyi Stock Based Fees To Directors And Consulants
StockBasedFeesToDirectorsAndConsulants
16000
CY2015Q1 bkyi Term Of Warrant
TermOfWarrant
P1Y
CY2017Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
117891
CY2016Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
53638
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
153692
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
466842
CY2017Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2646256
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3647031
CY2017Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
576256
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1577031
CY2017Q1 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2070000
CY2016Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2070000
CY2017Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1632471
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3133246
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
562471
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1563246
CY2017Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1070000
CY2016Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1570000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
380015
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
335323
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78155431
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78253413
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
161089
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
174363
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
500000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
1000000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3402
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3401
CY2017Q1 us-gaap Assets
Assets
15624039
CY2016Q4 us-gaap Assets
Assets
17289365
CY2017Q1 us-gaap Assets Current
AssetsCurrent
4407086
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4910296
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
11216953
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12379069
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6096920
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6093843
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
610
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1158421
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1061307
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4321078
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3474648
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
97114
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-846430
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.52
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
47917
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6096920
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6093843
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
609
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
660934
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
111848
CY2017Q1 us-gaap Cost Of Services
CostOfServices
38820
CY2016Q1 us-gaap Cost Of Services
CostOfServices
55782
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
489738
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
633062
CY2017Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712
CY2017Q1 us-gaap Depreciation
Depreciation
7819
CY2016Q1 us-gaap Depreciation
Depreciation
11518
CY2017Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
601875
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
401250
CY2017Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
200625
CY2016Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
200625
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2017Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
CY2016Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-38
CY2017Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
CY2016Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-38
CY2017Q1 us-gaap Gross Profit
GrossProfit
757401
CY2016Q1 us-gaap Gross Profit
GrossProfit
318744
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-313150
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-529924
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000775
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1167758
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
44692
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-181001
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-143324
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
78886
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
105527
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
110208
CY2017Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
64253
CY2016Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
109681
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13171
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3524
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144623
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
134132
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6
CY2017Q1 us-gaap Interest Paid
InterestPaid
CY2016Q1 us-gaap Interest Paid
InterestPaid
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19287
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
116953
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-661588
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1356187
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1163214
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
190653
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
381762
CY2017Q1 us-gaap Inventory Net
InventoryNet
570955
CY2016Q4 us-gaap Inventory Net
InventoryNet
465428
CY2017Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
380302
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
83666
CY2017Q1 us-gaap Liabilities
Liabilities
1625320
CY2016Q4 us-gaap Liabilities
Liabilities
1836477
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15624039
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17289365
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1625320
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1836477
CY2017Q1 us-gaap License Costs
LicenseCosts
622114
CY2016Q1 us-gaap License Costs
LicenseCosts
56066
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-5946
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-165555
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13893
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1556812
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1363839
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
2113594
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
1481926
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1356193
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1163182
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
117891
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53638
CY2017Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1097748
CY2016Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
145866
CY2017Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2016Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
133851
CY2017Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5946
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
31704
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13893
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19287
CY2015Q4 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
180000
CY2017Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200625
CY2016Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
200625
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
167348
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
206677
CY2017Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Reclassification</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.2pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.2pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications. The reclassifications have no effect on the reported net loss.</div></div></div></div></div></div></div></div>
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59995
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67814
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
500000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493444
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
489401
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64157342
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62801154
CY2017Q1 us-gaap Revenues
Revenues
1418335
CY2016Q1 us-gaap Revenues
Revenues
430592
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
320587
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
284726
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1620150
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
992525
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
156086
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
158363
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
13998719
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
15452888
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6094955
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5510381

Files In Submission

Name View Source Status
0001437749-17-009271-index-headers.html Edgar Link pending
0001437749-17-009271-index.html Edgar Link pending
0001437749-17-009271.txt Edgar Link pending
0001437749-17-009271-xbrl.zip Edgar Link pending
bkyi-20170331.xml Edgar Link completed
bkyi-20170331.xsd Edgar Link pending
bkyi-20170331_cal.xml Edgar Link unprocessable
bkyi-20170331_def.xml Edgar Link unprocessable
bkyi-20170331_lab.xml Edgar Link unprocessable
bkyi-20170331_pre.xml Edgar Link unprocessable
bkyi20170331_10q.htm Edgar Link pending
ex10-4.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending